Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin.
Saved in:
| Title: | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long-Acting FGF21 Analog Zalfermin. |
|---|---|
| Authors: | Dahl K; Novo Nordisk A/S, Bagsværd, Denmark., Friedrichsen MH; Novo Nordisk A/S, Bagsværd, Denmark., Ribel-Madsen R; Novo Nordisk A/S, Bagsværd, Denmark., Hansen JS; Novo Nordisk A/S, Bagsværd, Denmark., Clausen JO; Novo Nordisk A/S, Bagsværd, Denmark., Axelsen M; Gubra A/S, Hørsholm, Denmark., Palle MS; Novo Nordisk A/S, Bagsværd, Denmark., Lippert SL; Novo Nordisk A/S, Bagsværd, Denmark., Björkdahl O; Novo Nordisk A/S, Bagsværd, Denmark., Toubro S; Novo Nordisk A/S, Bagsværd, Denmark., Key C; ICON Early Phase Service, San Antonio, Texas, USA., Andersen B; Novo Nordisk A/S, Bagsværd, Denmark. |
| Source: | Clinical and translational science [Clin Transl Sci] 2025 Dec; Vol. 18 (12), pp. e70435. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.70435 |
